Insider Transactions in Q1 2022 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
George Demetri |
SELL
Open market or private sale
|
Direct |
10
-0.17%
|
$580
$58.56 P/Share
|
|
Mar 16
2022
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,219
-6.55%
|
$133,140
$60.0 P/Share
|
|
Mar 10
2022
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,339
-19.57%
|
$133,323
$57.15 P/Share
|
|
Mar 07
2022
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,047
-3.0%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
1,047
-1.83%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,047
-2.5%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,048
-1.14%
|
$58,688
$56.18 P/Share
|
|
Mar 07
2022
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,047
-2.61%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,047
-2.36%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
502
-2.06%
|
$28,112
$56.19 P/Share
|
|
Mar 07
2022
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,047
-2.3%
|
$58,632
$56.19 P/Share
|
|
Mar 07
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
4,843
-2.57%
|
$271,208
$56.19 P/Share
|
|
Mar 07
2022
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
256
-2.1%
|
$14,336
$56.19 P/Share
|
|
Mar 04
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
20,000
-2.48%
|
$1,140,000
$58.0 P/Share
|
|
Mar 04
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.68%
|
$160,000
$8.44 P/Share
|
|
Mar 03
2022
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,491
-3.44%
|
$89,460
$60.27 P/Share
|
|
Mar 03
2022
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,719
-1.83%
|
$103,140
$60.27 P/Share
|
|
Mar 03
2022
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,328
-3.21%
|
$79,680
$60.27 P/Share
|
|
Mar 03
2022
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,667
-3.63%
|
$100,020
$60.28 P/Share
|
|
Mar 03
2022
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
1,066
-4.2%
|
$63,960
$60.27 P/Share
|
|
Mar 03
2022
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,197
-2.56%
|
$71,820
$60.28 P/Share
|
|
Mar 03
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
7,862
-4.01%
|
$471,720
$60.28 P/Share
|
|
Mar 03
2022
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
761
-5.87%
|
$45,660
$60.27 P/Share
|
|
Mar 03
2022
|
Mark Alan Goldberg |
BUY
Open market or private purchase
|
Direct |
5,000
+31.62%
|
$295,000
$59.98 P/Share
|
|
Mar 01
2022
|
Jeffrey W. Albers |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+3.69%
|
-
|
|
Mar 01
2022
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+20.74%
|
-
|
|
Mar 01
2022
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+20.38%
|
-
|
|
Mar 01
2022
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+21.39%
|
-
|
|
Mar 01
2022
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+23.19%
|
-
|
|
Mar 01
2022
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+20.03%
|
-
|
|
Mar 01
2022
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+29.86%
|
-
|
|
Mar 01
2022
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+22.24%
|
-
|
|
Mar 01
2022
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+24.3%
|
-
|
|
Mar 01
2022
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+22.37%
|
-
|
|
Mar 01
2022
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+18.14%
|
-
|